This list is based on the watchlists of people on Stock Events who follow AYAUF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.
Show more...
FAQ
What is Artrya stock price today?▼
The current price of AYAUF is $2.75 USD — it has increased by +0% in the past 24 hours. Watch Artrya stock price performance more closely on the chart.
What is Artrya stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Artrya stocks are traded under the ticker AYAUF.
What is Artrya market cap?▼
Today Artrya has the market capitalization of 560.6M
When is the next Artrya earnings date?▼
Artrya is going to release the next earnings report on March 02, 2027.
What were Artrya earnings last quarter?▼
AYAUF earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.04 USD resulting in a -61.12% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Artrya revenue for the last year?▼
Artrya revenue for the last year amounts to 19,020.25 USD.
What is Artrya net income for the last year?▼
AYAUF net income for the last year is -17.15M USD.
How many employees does Artrya have?▼
As of September 05, 2026, the company has 43 employees.
In which sector is Artrya located?▼
Artrya operates in the Other sector.
When did Artrya complete a stock split?▼
Artrya has not had any recent stock splits.